Lochner Daniel — SEC insider filings

SEC reporting owner CIK 1791187. 23 insider filings on record with FilingPulse; latest filed 2026-10-02.

Transaction summary — filings shown

Covers all 23 filings on record, filed 2020-08-12 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Tectonic Therapeutic, Inc. (TECX)Chief Financial Officer102 legs · 10,617 sh · $379,624—11
Oyster Point Pharma, Inc. (OYST)Chief Financial Officer13——29

Insider filings — Lochner Daniel

FiledFormIssuerReported transactionsSource
2026-10-024Tectonic Therapeutic, Inc. (TECX)Tax withholding (F): 520 @ $23.67EDGAR
2026-09-084Tectonic Therapeutic, Inc. (TECX)Grant/award (A): 24,250 (derivative) @ $0EDGAR
2026-06-124Tectonic Therapeutic, Inc. (TECX)Grant/award (A): 7,500 (derivative) @ $0EDGAR
2026-03-054Tectonic Therapeutic, Inc. (TECX)Grant/award (A): 26,500 @ $0 · Grant/award (A): 24,250 (derivative) @ $0EDGAR
2026-02-114Tectonic Therapeutic, Inc. (TECX)Purchase (P): 6,000 @ $21.61EDGAR
2026-02-104Tectonic Therapeutic, Inc. (TECX)Tax withholding (F): 2,077 @ $23.22EDGAR
2025-09-294Tectonic Therapeutic, Inc. (TECX)Grant/award (A): 5,430 @ $0 · Grant/award (A): 9,860 (derivative) @ $0EDGAR
2025-02-074Tectonic Therapeutic, Inc. (TECX)Purchase (P): 4,617 @ $54.14EDGAR
2025-02-064Tectonic Therapeutic, Inc. (TECX)Grant/award (A): 18,074 @ $0 · Grant/award (A): 32,862 (derivative) @ $0EDGAR
2024-06-244Tectonic Therapeutic, Inc. (TECX)Grant/award (A): 118,000 (derivative) @ $0EDGAR
2023-01-044Oyster Point Pharma, Inc. (OYST)Tax withholding (F): 938 @ $11.70 · Code (U): 56,289 · Disposition to issuer (D): 20,236 · Disposition to issuer (D): 300,000 (derivative) · Disposition to issuer (D): 161,251 (derivative) · Disposition to issuer (D): 72,648 (derivative) · +3 moreEDGAR
2022-12-064Oyster Point Pharma, Inc. (OYST)Tax withholding (F): 3,258 @ $11.20EDGAR
2022-07-084Oyster Point Pharma, Inc. (OYST)Grant/award (A): 300,000 (derivative) @ $0EDGAR
2022-01-114Oyster Point Pharma, Inc. (OYST)Grant/award (A): 19,500 @ $0 · Grant/award (A): 87,900 (derivative) @ $0EDGAR
2021-11-024Oyster Point Pharma, Inc. (OYST)Option exercise (M): 8,590 @ $11.51 · Option exercise (M): 8,590 (derivative) @ $0EDGAR
2021-09-074Oyster Point Pharma, Inc. (OYST)Option exercise (M): 7,500 @ $11.51 · Option exercise (M): 7,500 (derivative) @ $0EDGAR
2021-08-304Oyster Point Pharma, Inc. (OYST)Grant/award (A): 45,000 (derivative) @ $0EDGAR
2021-07-294Oyster Point Pharma, Inc. (OYST)Option exercise (M): 7,500 @ $11.51 · Option exercise (M): 7,500 (derivative) @ $0EDGAR
2021-02-264Oyster Point Pharma, Inc. (OYST)Option exercise (M): 9,109 @ $11.51 · Option exercise (M): 9,109 (derivative) @ $0EDGAR
2021-02-024Oyster Point Pharma, Inc. (OYST)Grant/award (A): 11,222 @ $0 · Grant/award (A): 50,500 (derivative) @ $0EDGAR
2020-09-284Oyster Point Pharma, Inc. (OYST)Option exercise (M): 4,000 @ $11.51 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2020-08-184/AOyster Point Pharma, Inc. (OYST)Option exercise (M): 4,000 @ $11.51EDGAR
2020-08-124Oyster Point Pharma, Inc. (OYST)Option exercise (M): 4,000 @ $11.51 · Option exercise (M): 4,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1791187 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs